OptimizeRx Appoints Mary Varghese Presti to Board of Directors

OptimizeRx Corporation announced the appointment of Mary Varghese Presti to its Board of Directors, expanding the board to seven members. Ms. Varghese Presti, COO of Microsoft’s Health & Life Sciences organization, brings over 25 years of experience in healthcare, life sciences, and technology, with expertise in scaling platforms, commercializing innovation, and driving operational efficiency. Her appointment is part of the company's ongoing board refreshment process. Ms. Varghese Presti will also serve on the Audit Committee and will participate in the company's non-employee director compensation program, including an annual cash retainer of $45,000, an annual equity grant valued at approximately $175,000, and an additional $10,000 retainer for her role on the Audit Committee. The company also issued a press release on April 8, 2026, announcing this appointment.